The University of Kansas Cancer Center, Investigational Drug Services — Fairway, Kansas

The University of Kansas Cancer Center, Investigational Drug Services is a clinical research site located in Fairway, Kansas, United States 66205.

Crixeo Clinical Trials Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

The University of Kansas Cancer Center, Investigational Drug Services has participated in 6 clinical trials with 4 currently active.

Therapeutic areas: Non-Small Cell Lung Cancer, Triple-negative Breast Cancer, Colorectal Neoplasms.

Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fairway

Browse all research sites in Kansas · View every site in Fairway

• University of Kansas Hospital
• University of Kansas Medical Center CTSU Fairway - Appendix A & B
• University of Kansas Medical Center
• The University of Kansas Cancer Center - Clinical Research Center - Fairway Office Park
• Kansas University Clinical Research Center
• University of Kansas Cancer Center /ID# 218144
• University of Kansas Cancer Center, Clinical Research Center, 4350 Shawnee Mission Parkway, MS 6004
• Kansas University Alzheimer's Disease Center (KUADC)
• The University of Kansas Alzheimer's Disease Research Center
• The University of Kansas Clini /ID# 162915
• University of Kansas Cancer Center /ID# 201292
• The University of Kansas Medical Center Research Institute

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Kansas Cancer Center, Investigational Drug Services?

The University of Kansas Cancer Center, Investigational Drug Services has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Kansas Cancer Center, Investigational Drug Services conducted?

The University of Kansas Cancer Center, Investigational Drug Services has 6 clinical trials on record, with 4 currently active. Their work covers Non-Small Cell Lung Cancer, Triple-negative Breast Cancer, Colorectal Neoplasms.

Is The University of Kansas Cancer Center, Investigational Drug Services accredited by Crixeo Clinical Trials?

The University of Kansas Cancer Center, Investigational Drug Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The University of Kansas Cancer Center, Investigational Drug Services?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.